GENERATING SYNERGY BETWEEN PROTEIN AND NON PROTEIN MACROMOLECULAR ADJUVANTS
Award amount
$224,992Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Hafion Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- G41ASXW94LC5
- Solicitation number
- Not reported
- Topic code
- NIAID
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Formulation of a prophylactic vaccine against Pseudomonas aeruginosa
- Production of a Nanoparticle Vaccine to Aid in Smoking Cessation
- Toward the Development of a Protein: Non-protein Macromolecular Adjuvants
- Determination of protective efficacy of multimeric Shigella vaccine as the next step toward human trials
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
Research funding history
5 SBIR/STTR records share this UEI (2017–2022). Reported award amounts total $1,662,566. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services